Skip to Content

Tag: ResMed


News

In brief: Stakeholders push SWO, ResMed buys into HST, Etac adds Ki Mobility

October 8, 2021HME News Staff

WASHINGTON – AAHomecare, VGM & Associates, the Council for Quality Respiratory Care and 11 other organizations are asking CMS to eliminate the medical record review for home oxygen therapy and to accept the clinician prescription/standard written order as the required documentation for establishing medical necessity.  These changes would protect against fraud and abuse, reduce the burden on clinicians and suppliers, and protect access for Medicare beneficiaries, the groups say in an...

Etac, Home oxygen therapy, Home Sleep Testing, Ki Mobility, ResMed, standard written order


Read Full Articlered right arrow icon

Jim Hollingshead

Vendors

ResMed buys HST company

October 4, 2021HME News Staff

SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.  The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.  "Sleep labs and home tests each have critical roles to...

CPAP Therapy, Ectosense, Home Sleep Testing, NightOwl, Obstructive Sleep Apnea, ResMed


Read Full Articlered right arrow icon

Study: CPAP therapy can improve lifespan

Vendors

Study: CPAP therapy can improve lifespan

September 9, 2021HME News Staff

LYON, France – Using PAP therapy can significantly increase sleep apnea patients’ chances of living longer, according to an abstract presented this week at the virtual European Respiratory Society (ERS) International Congress 2021 and supported by ResMed.  The landmark ALASKA study, “CPAP Termination and All-Cause Mortality: a French Nationwide Database Analysis,” concluded people with obstructive sleep apnea who continued PAP therapy were 39% more likely to survive...

CPAP, ResMed, Sleep Apnea


Read Full Articlered right arrow icon

Also Noted

NYU charges ResMed with patent infringement

September 7, 2021HME News Staff

NEW YORK – New York University has filed a complaint for patent infringement against ResMed. The complaint, filed in Delaware, alleges that ResMed commits acts of patent infringement through the manufacture, use, offer for sale, sale and/or importation of the company’s AirSense 10 AutoSet systems that include the AutoSet algorithm and AutoRamp features. The AutoSet algorithm monitors a patient's breathing pattern to determine the ideal pressure to use for treatment; the AutoRamp...

AirSense, New York University, Patent infringement, ResMed


Read Full Articlered right arrow icon

Also Noted

ResMed taps Ghoshal to head SaaS business

August 26, 2021HME News Staff

SAN DIEGO – ResMed has promoted Bobby Ghoshal to president of the SaaS business effective immediately, replacing Raj Sodhi, who will leave Sept. 1. Ghoshal has more than 25 years of experiences across medical and technology industries, most recently as ResMed’s chief technology officer. From February 2016 to April 2018, he served as COO for Brightree, which is owned by ResMed. “As we look ahead to 2025, we believe the future of healthcare is outside the hospital and we have an amazing...

Bobby Ghoshal, Brightree, ResMed, Saas


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed calls demand ‘extraordinary, unprecedented’

August 13, 2021Liz Beaulieu, Editor

SAN DIEGO – ResMed expects to post $300 million to $350 million in additional revenue in its fiscal year 2022 as a result of a voluntary recall of certain Philips CPAP/BiLevel and ventilator devices, company officials said during an Aug. 5 conference call to discuss recent financial results.  In the fourth quarter of its fiscal year 2021, ResMed saw a 30% increase in device sales in the U.S., Canada and Latin America.  “We estimate that we generated an incremental device...

CPAP, Home Respiratory Equipment, ResMed


Read Full Articlered right arrow icon

News

In brief: ResMed shows ‘strength,’ Apria’s ‘ahead,’ CMS provides bid comparison

August 6, 2021HME News Staff

SAN DIEGO – ResMed reported revenue increased 14% to $876.1 million for the fourth quarter of 2021 compared to the same period last year. Net income was $195.1 million vs. $177.8 million.  The company reported revenue increased 8% to $3.2 billion for fiscal year 2021 compared to the previous year. Net income was $474.5 million vs. $621.7 million.  “Our fourth quarter and full-year fiscal year 2021 results continue to demonstrate the strength and resiliency of our business,”...

AOPA, Apria, CRT, Kubat HealthCare, Lifeway Mobility, NCART, NRRTS, ResMed, WellSky


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed shows ‘strength'

August 6, 2021HME News Staff

SAN DIEGO – ResMed reported revenue increased 14% to $876.1 million for the fourth quarter of 2021 compared to the same period last year. Net income was $195.1 million vs. $177.8 million.  The company reported revenue increased 8% to $3.2 billion for fiscal year 2021 compared to the previous year. Net income was $474.5 million vs. $621.7 million.  “Our fourth quarter and full-year fiscal year 2021 results continue to demonstrate the strength and resiliency of our business,”...

Home Respiratory Equipment, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Vendors

‘It’s a perfect storm’: Manufacturers prioritize, allocate orders for CPAP devices

June 25, 2021Liz Beaulieu, Editor

YARMOUTH, Maine – Manufacturers like ResMed and 3B Medical are ramping up production to meet increased demand due to a voluntary recall of millions of Philips CPAP devices, but their efforts are complicated by supply chain and other challenges.  “Yes, we’re ramping up production as quickly as possible, while working closely with our global supplier network to navigate the well-known global supply chain challenges impacting this and other industries,” said Jayme...

3B Medical, CPAP, Fisher & Paykel, Philips Recall, ResMed


Read Full Articlered right arrow icon

Vendors

New research links untreated OSA, COVID-19 infections

June 14, 2021HME News Staff

SAN DIEGO – People with untreated obstructive sleep apnea were associated with a higher rate of COVID-19 infection than those who received PAP treatment, according to a poster presented by ResMed and Kaiser Permanente during SLEEP 2021, which was held virtually June 10-13.  The data showed a dose-response association of OSA severity on infection rate: Patients with untreated mild OSA had a COVID-19 infection rate of 2%, while patients with severe untreated OSA had a COVID-19 infection...

COVID-19, Obstructive Sleep Apnea, Research, ResMed


Read Full Articlered right arrow icon